Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ron Cohen
Pharma
Slow Inbrija launch forces Acorda to slash $800M sales hopes
Acorda had high hopes for Parkinson's med Inbrija, aiming for$800 million in peak sales, but a lackluster year has the company rethinking that goal.
Kyle Blankenship
Feb 13, 2020 10:52am
Acorda's sales team switches gears to promote Inbrija
Jan 15, 2019 11:20am
Acorda's much-needed Inbrija hits a snag at the FDA
Sep 13, 2018 11:20am
Activist presses Ampyra maker Acorda to put itself on the block
Aug 7, 2017 11:19am
Court nixes Ampyra patents, teeing up 2018 generics
Apr 3, 2017 10:33am
